Kam padedameMūsų mokslasProduktaiRezultatai
PrisijungtiKlaustiPradėtinuo 449 $
Požymis
Blood in urine
Klinikinis pavadinimas: Hematuria
The presence of blood in the urine. Hematuria may be gross hematuria (visible to the naked eye) or microscopic hematuria (detected by dipstick or microscopic examination of the urine).
Santrauka
- Taip pat vadinama
- High urine occult blood
Blood in urineHP:0000790
Kam padedameMūsų mokslasProduktaiRezultatai
PrisijungtiKlaustiPradėtinuo 449 $
Read the genes linked to Blood in urine, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test163 genų susiję su Blood in urine
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Blood in urine. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| APRTadenine phosphoribosyltransferase | Visada | 1 ligoje |
| CTNScystinosin, lysosomal cystine transporter | Visada | 1 ligoje |
| HMOX1heme oxygenase 1 | Visada | 1 ligoje |
| IFT140intraflagellar transport 140 | Visada | 2 ligose |
| LAMB2laminin subunit beta 2 | Visada | 1 ligoje |
| LARS2leucyl-tRNA synthetase 2, mitochondrial | Visada | 1 ligoje |
| MCCC1methylcrotonyl-CoA carboxylase subunit 1 | Visada | 1 ligoje |
| MYO1Emyosin IE | Visada | 1 ligoje |
| PLD4phospholipase D family member 4 | Visada | 1 ligoje |
| COL4A3collagen type IV alpha 3 chain | Labai dažnai (80–99%) | 3 ligose |
| COL4A4collagen type IV alpha 4 chain | Labai dažnai (80–99%) | 4 ligose |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Labai dažnai (80–99%) | 2 ligose |
| GLAgalactosidase alpha | Labai dažnai (80–99%) | 1 ligoje |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Labai dažnai (80–99%) | 1 ligoje |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Labai dažnai (80–99%) | 1 ligoje |
| HOGA14-hydroxy-2-oxoglutarate aldolase 1 | Labai dažnai (80–99%) | 1 ligoje |
| PRTN3proteinase 3 | Labai dažnai (80–99%) | 1 ligoje |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Labai dažnai (80–99%) | 3 ligose |
| AGXTalanine--glyoxylate aminotransferase | Dažnai (30–79%) | 2 ligose |
| ALG5ALG5 dolichyl-phosphate beta-glucosyltransferase | Dažnai (30–79%) | 1 ligoje |
| ALG9ALG9 alpha-1,2-mannosyltransferase | Dažnai (30–79%) | 1 ligoje |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Dažnai (30–79%) | 1 ligoje |
| BICC1BicC family RNA binding protein 1 | Dažnai (30–79%) | 1 ligoje |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Dažnai (30–79%) | 1 ligoje |
| C4Acomplement C4A (Chido/Rodgers blood group) | Dažnai (30–79%) | 1 ligoje |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Dažnai (30–79%) | 1 ligoje |
| CLDN19claudin 19 | Dažnai (30–79%) | 1 ligoje |
| COL4A1collagen type IV alpha 1 chain | Dažnai (30–79%) | 2 ligose |
| COL4A5collagen type IV alpha 5 chain | Dažnai (30–79%) | 1 ligoje |
| COL4A6collagen type IV alpha 6 chain | Dažnai (30–79%) | 1 ligoje |
| CR2complement C3d receptor 2 | Dažnai (30–79%) | 1 ligoje |
| DGKEdiacylglycerol kinase epsilon | Dažnai (30–79%) | 1 ligoje |
| DNAJB11DnaJ heat shock protein family (Hsp40) member B11 | Dažnai (30–79%) | 1 ligoje |
| DNASE1deoxyribonuclease 1 | Dažnai (30–79%) | 1 ligoje |
| DNASE1L3deoxyribonuclease 1L3 | Dažnai (30–79%) | 1 ligoje |
| ETS1ETS proto-oncogene 1, transcription factor | Dažnai (30–79%) | 1 ligoje |
| FCGR2BFc gamma receptor IIb | Dažnai (30–79%) | 1 ligoje |
| FCGR3BFc gamma receptor IIIb | Dažnai (30–79%) | 1 ligoje |
| GANABglucosidase II alpha subunit | Dažnai (30–79%) | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Dažnai (30–79%) | 2 ligose |
Rodyti dar 123 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| HNF1BHNF1 homeobox B | Dažnai (30–79%) | 1 ligoje |
| HPRT1hypoxanthine phosphoribosyltransferase 1 | Dažnai (30–79%) | 1 ligoje |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Dažnai (30–79%) | 1 ligoje |
| IL10interleukin 10 | Dažnai (30–79%) | 1 ligoje |
| IRAK1interleukin 1 receptor associated kinase 1 | Dažnai (30–79%) | 2 ligose |
| IRF5interferon regulatory factor 5 | Dažnai (30–79%) | 1 ligoje |
| ITGA6integrin subunit alpha 6 | Dažnai (30–79%) | 1 ligoje |
| ITGAMintegrin subunit alpha M | Dažnai (30–79%) | 1 ligoje |
| ITGB4integrin subunit beta 4 | Dažnai (30–79%) | 1 ligoje |
| JAZF1JAZF zinc finger 1 | Dažnai (30–79%) | 1 ligoje |
| KANK2KN motif and ankyrin repeat domains 2 | Dažnai (30–79%) | 1 ligoje |
| KIAA0319LKIAA0319 like | Dažnai (30–79%) | 1 ligoje |
| MECP2methyl-CpG binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| NEK8NIMA related kinase 8 | Dažnai (30–79%) | 1 ligoje |
| PAX2paired box 2 | Dažnai (30–79%) | 1 ligoje |
| PDCD1programmed cell death 1 | Dažnai (30–79%) | 1 ligoje |
| PFKMphosphofructokinase, muscle | Dažnai (30–79%) | 1 ligoje |
| PKD1polycystin 1, transient receptor potential channel interacting | Dažnai (30–79%) | 1 ligoje |
| PKD2polycystin 2, transient receptor potential cation channel | Dažnai (30–79%) | 1 ligoje |
| PXKPX domain containing serine/threonine kinase like | Dažnai (30–79%) | 1 ligoje |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Dažnai (30–79%) | 1 ligoje |
| SERPINF2serpin family F member 2 | Dažnai (30–79%) | 1 ligoje |
| SLC7A7solute carrier family 7 member 7 | Dažnai (30–79%) | 1 ligoje |
| SPP1secreted phosphoprotein 1 | Dažnai (30–79%) | 2 ligose |
| SPRY2sprouty RTK signaling antagonist 2 | Dažnai (30–79%) | 1 ligoje |
| STAT4signal transducer and activator of transcription 4 | Dažnai (30–79%) | 2 ligose |
| STIM1stromal interaction molecule 1 | Dažnai (30–79%) | 1 ligoje |
| TLR7toll like receptor 7 | Dažnai (30–79%) | 1 ligoje |
| TNFAIP3TNF alpha induced protein 3 | Dažnai (30–79%) | 1 ligoje |
| TNFSF4TNF superfamily member 4 | Dažnai (30–79%) | 1 ligoje |
| TNIP1TNFAIP3 interacting protein 1 | Dažnai (30–79%) | 1 ligoje |
| TREX1three prime repair exonuclease 1 | Dažnai (30–79%) | 2 ligose |
| TSC1TSC complex subunit 1 | Dažnai (30–79%) | 1 ligoje |
| TSC2TSC complex subunit 2 | Dažnai (30–79%) | 1 ligoje |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Dažnai (30–79%) | 1 ligoje |
| YAP1Yes1 associated transcriptional regulator | Dažnai (30–79%) | 2 ligose |
| ACP5acid phosphatase 5, tartrate resistant | Kartais (5–29%) | 1 ligoje |
| AGGF1angiogenic factor with G-patch and FHA domains 1 | Kartais (5–29%) | 1 ligoje |
| BNC2basonuclin zinc finger protein 2 | Kartais (5–29%) | 1 ligoje |
| CD109CD109 molecule | Kartais (5–29%) | 1 ligoje |
| CLEC7AC-type lectin domain containing 7A | Kartais (5–29%) | 1 ligoje |
| DLSTdihydrolipoamide S-succinyltransferase | Kartais (5–29%) | 1 ligoje |
| DNMT3ADNA methyltransferase 3 alpha | Kartais (5–29%) | 1 ligoje |
| DPH1diphthamide biosynthesis 1 | Kartais (5–29%) | 1 ligoje |
| EPAS1endothelial PAS domain protein 1 | Kartais (5–29%) | 1 ligoje |
| F10coagulation factor X | Kartais (5–29%) | 1 ligoje |
| F5coagulation factor V | Kartais (5–29%) | 1 ligoje |
| F8coagulation factor VIII | Kartais (5–29%) | 1 ligoje |
| F9coagulation factor IX | Kartais (5–29%) | 1 ligoje |
| FAN1FANCD2 and FANCI associated nuclease 1 | Kartais (5–29%) | 1 ligoje |
| FCGR2CFc gamma receptor IIc (gene/pseudogene) | Kartais (5–29%) | 1 ligoje |
| FHfumarate hydratase | Kartais (5–29%) | 1 ligoje |
| GBA1glucosylceramidase beta 1 | Kartais (5–29%) | 2 ligose |
| GP1BAglycoprotein Ib platelet subunit alpha | Kartais (5–29%) | 1 ligoje |
| GP1BBglycoprotein Ib platelet subunit beta | Kartais (5–29%) | 1 ligoje |
| HLA-Bmajor histocompatibility complex, class I, B | Kartais (5–29%) | 1 ligoje |
| IL17Finterleukin 17F | Kartais (5–29%) | 1 ligoje |
| IL17RAinterleukin 17 receptor A | Kartais (5–29%) | 1 ligoje |
| IL17RCinterleukin 17 receptor C | Kartais (5–29%) | 1 ligoje |
| ITGA2integrin subunit alpha 2 | Kartais (5–29%) | 1 ligoje |
| ITGA2Bintegrin subunit alpha 2b | Kartais (5–29%) | 1 ligoje |
| ITGB3integrin subunit beta 3 | Kartais (5–29%) | 1 ligoje |
| KIF1Bkinesin family member 1B | Kartais (5–29%) | 1 ligoje |
| LMAN1lectin, mannose binding 1 | Kartais (5–29%) | 1 ligoje |
| LMX1BLIM homeobox transcription factor 1 beta | Kartais (5–29%) | 2 ligose |
| MAXMYC associated transcriptional regulator X | Kartais (5–29%) | 1 ligoje |
| MCFD2multiple coagulation factor deficiency 2, ER cargo receptor complex subunit | Kartais (5–29%) | 1 ligoje |
| MDH2malate dehydrogenase 2 | Kartais (5–29%) | 1 ligoje |
| NF1neurofibromin 1 | Kartais (5–29%) | 1 ligoje |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Kartais (5–29%) | 1 ligoje |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Kartais (5–29%) | 1 ligoje |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Kartais (5–29%) | 1 ligoje |
| RETret proto-oncogene | Kartais (5–29%) | 2 ligose |
| SCARB2scavenger receptor class B member 2 | Kartais (5–29%) | 1 ligoje |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Kartais (5–29%) | 1 ligoje |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Kartais (5–29%) | 1 ligoje |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Kartais (5–29%) | 2 ligose |
| SDHCsuccinate dehydrogenase complex subunit C | Kartais (5–29%) | 1 ligoje |
| SDHDsuccinate dehydrogenase complex subunit D | Kartais (5–29%) | 2 ligose |
| SLC22A12solute carrier family 22 member 12 | Kartais (5–29%) | 1 ligoje |
| SLC25A11solute carrier family 25 member 11 | Kartais (5–29%) | 1 ligoje |
| SLC2A9solute carrier family 2 member 9 | Kartais (5–29%) | 1 ligoje |
| SREBF1sterol regulatory element binding transcription factor 1 | Kartais (5–29%) | 1 ligoje |
| TMEM127transmembrane protein 127 | Kartais (5–29%) | 1 ligoje |
| TRAF3IP2TRAF3 interacting protein 2 | Kartais (5–29%) | 1 ligoje |
| UMODuromodulin | Kartais (5–29%) | 1 ligoje |
| VHLvon Hippel-Lindau tumor suppressor | Kartais (5–29%) | 2 ligose |
| BCORBCL6 corepressor | Retai (1–4 %) | 1 ligoje |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Retai (1–4 %) | 1 ligoje |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Retai (1–4 %) | 1 ligoje |
| NABP1nucleic acid binding protein 1 | Retai (1–4 %) | 1 ligoje |
| NPM1nucleophosmin 1 | Retai (1–4 %) | 1 ligoje |
| NUMA1nuclear mitotic apparatus protein 1 | Retai (1–4 %) | 1 ligoje |
| PMLPML nuclear body scaffold | Retai (1–4 %) | 1 ligoje |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Retai (1–4 %) | 1 ligoje |
| RARAretinoic acid receptor alpha | Retai (1–4 %) | 1 ligoje |
| SLC34A2solute carrier family 34 member 2 | Retai (1–4 %) | 1 ligoje |
| SLC5A1solute carrier family 5 member 1 | Retai (1–4 %) | 1 ligoje |
| SPTBN1spectrin beta, non-erythrocytic 1 | Retai (1–4 %) | 1 ligoje |
| STAT3signal transducer and activator of transcription 3 | Retai (1–4 %) | 1 ligoje |
| STAT5Bsignal transducer and activator of transcription 5B | Retai (1–4 %) | 1 ligoje |
| TBL1XR1TBL1X/Y related 1 | Retai (1–4 %) | 1 ligoje |
| ZBTB16zinc finger and BTB domain containing 16 | Retai (1–4 %) | 1 ligoje |
| C3complement C3 | Neužfiksuota | 1 ligoje |
| CD2APCD2 associated protein | Neužfiksuota | 1 ligoje |
| CD46CD46 molecule | Neužfiksuota | 1 ligoje |
| CFBcomplement factor B | Neužfiksuota | 1 ligoje |
| CFHcomplement factor H | Neužfiksuota | 1 ligoje |
| CFIcomplement factor I | Neužfiksuota | 1 ligoje |
| CLDN16claudin 16 | Neužfiksuota | 1 ligoje |
| FGAfibrinogen alpha chain | Neužfiksuota | 1 ligoje |
| GATA3GATA binding protein 3 | Neužfiksuota | 1 ligoje |
| GRHPRglyoxylate and hydroxypyruvate reductase | Neužfiksuota | 1 ligoje |
| HBBhemoglobin subunit beta | Neužfiksuota | 1 ligoje |
| LMNB2lamin B2 | Neužfiksuota | 1 ligoje |
| MMACHCmetabolism of cobalamin associated C | Neužfiksuota | 1 ligoje |
| NOTCH2notch receptor 2 | Neužfiksuota | 1 ligoje |
| NUP133nucleoporin 133 | Neužfiksuota | 1 ligoje |
| NUP93nucleoporin 93 | Neužfiksuota | 1 ligoje |
| PRDX1peroxiredoxin 1 | Neužfiksuota | 1 ligoje |
| SLC37A4solute carrier family 37 member 4 | Neužfiksuota | 1 ligoje |
| THBDthrombomodulin | Neužfiksuota | 1 ligoje |
| UMPSuridine monophosphate synthetase | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Kam padedameMūsų mokslasProduktaiRezultatai
PrisijungtiKlaustiPradėtinuo 449 $
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites